SURF Surface Oncology
- 1.0700
- 0.00000.00%
Surface Oncology News
Coherus BioSciences Completes Acquisition of Surface Oncology
Coherus Completes Surface Oncology Acquisition
Surface Oncology Says Takeover by Coherus BioSciences Gets Backing From ISS, Glass Lewis
Surface Oncology Announces ISS And Glass Lewis Both Recommend Stockholders Vote "FOR" The Proposed Merger With Coherus BioSciences >SURF
Surface Oncology GAAP EPS of -$0.46
Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate
Express News | Surface Oncology: If Coherus Merger Isn't Approved by Shareholders, Cash Runway Extends Through 2023 >SURF
Express News | Surface Oncology 2Q R&D Expenses $13.8M >SURF
Surface Oncology | 8-K: Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
Express News | Surface Oncology 2Q Loss/Shr 46c >SURF
Press Release: Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares
Cathie Wood Sells $7M Tesla Stock Friday Amid Pullback, Bets Big On This Crypto-Linked Stock
Surface Oncology (SURF) Was Downgraded to a Hold Rating at JonesTrading
Ten Stocks Trending On Discord For Tuesday June 20, 2023: TEVA, BVS, ASB, CLNN, CTG, SURF, DICE, SPY, BABA, TASK
Wedbush Downgrades Surface Oncology to Neutral From Outperform, Adjusts Price Target to $1.15 From $3
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Surface Oncology, Inc. Buyout
Wedbush Downgrades Surface Oncology to Neutral
Analysis
Price Target
No Data
No Data